Pat Bird
In 2023, more than 155 million Americans, nearly half the U.S. population, will live in one of the 39 states or Washington DC in which marijuana is legalized for medical use.
As demand for cannabis continues to trend upward, there’s been an increase of product cultivation to meet this growing demand, resulting in a correlating uptick in the volume of microbiology testing required to ensure product can be released into the market.
Cannabis is a high-maintenance, agricultural commodity with complex cultivation considerations.
If you’re involved in any part of the seed-to-sale process, you must anticipate that a portion of your product will fail state limits – the standard failure rate for the industry is 10%-20% of the product that is tested.
ADVERTISEMENT
On the lookout for aspergillus
The most common cause of failure is high levels of fungal, or mold, contamination, specifically with a subset
Read full article on Marijuana Business Daily
